Compugen: COM701 Data On Track And Continued Bispecific Rilvegostomig Development

🇺🇸 Seeking Alpha (US) —
Compugen: COM701 Data On Track And Continued Bispecific Rilvegostomig Development

AI Summary

The article title indicates an update on Compugen’s COM701 data and continued development of the bispecific candidate rilvegostomig. No further details are provided in the supplied text.

Markets Health Compugen COM701 rilvegostomig bispecific drug development clinical data

Read original source →